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Abstract 
Background 
This study was conducted to identify cardiac dysfunction and the relationship of hemoglobin A1c 
(HbA1c) levels and serum lipids to echocardiographic indices in children and adolescents with 
T1DM. 
Materials and Methods: This  case-control study was conducted on  100 cases  including 50 children 
and adolescents aged 3-19 years old suffering T1DM for at least  two years and 50 age- and sex-
matched healthy subjects with the patients. This study was conducted in Shahrekord, Iran. All 
participants underwent TDI echocardiography and the levels of HbA1C and serum lipid were 
measured in diabetic patients. Then echocardio function of two groups were compared and the 
relation between these findings and HbA1C and lipids was evaluated. Data was analyzed using SPSS 
software (version 23.0). 
Results: MPI, E/A, E'/A', E wave, A wave, IVRT, ET, EDV, LVIDd and LVIDs were significantly 
different between diabetes and control groups (P<0.05). However, EF, E/ E', IVCT, ESV and EF 
values showed no significant difference between diabetes and control groups (P>0.05). A significant, 
positive correlation was observed between E/E' and TG (p=0.007, r= 0.37). E/A showed positive 
correlation with HDL (p=0.046, r=0.284) and negative correlation with TG (p = 0.048, r=-0.281), and 
LDL (P=0.012, r=-0.352). E'/A' showed positive correlation with HDL (p=0.033, r=0.302), and 
negative correlation with TG (p=0.014, r=-0.347) in diabetic patients.  
Conclusion 
In diabetic patients, first, cardiac diastolic function decreases, resulting in a decrease in E/A and E/A 
ratios as well as a decrease in myocardial performance index, which indicates systolic and diastolic 
function, and is recommended to be taken into account in the initial examination of the heart of 
diabetics and not to wait for late-onset systolic function change. 
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1- INTRODUCTION 
      Diabetes mellitus (DM) is a metabolic 
and multifaceted disorder characterized by 
hyperglycemia caused by insulin 
insufficiency or insulin resistance. Type I 
Diabetes mellitus (T1DM) is a 
heterozygous disease caused by 
autoimmune damage to pancreatic beta 
cells leading to insulin insufficiency (1). 
This disease is more commonly diagnosed 
in children and adolescents, accounting for 
90% of diabetes cases in children and 
adolescents, less than half of which can be 
diagnosed before the age of 15 (2). 
Mortality and morbidity of DM are due to 
microvascular complications including 
retinopathy, nephropathy and neuropathy 
and/or macrovascular complications such 
as coronary artery disease, carotid artery 
and other large vessels whose diagnosis is 
increased with the onset of disease in 
childhood (3). Generally, people with 
diabetes are at high risk of cardiovascular 
disease and warning signs of cardiac 
complications are often not recognized due 
to poor screening measures (4). In fact, the 
major cause of diabetes-related mortality is 
cardiovascular disease that is 2-5 times 
more common in diabetics than in normal 
population (5, 6).  
Hyperglycemia, high blood pressure, 
dyslipidemia and renal dysfunction are risk 
factors for cardiovascular complications in 
diabetic patients (7). Microvascular 
complications in diabetic patients are 
associated with an increase in mortality 
due to organ damage and increased risk of 
cardiovascular disease (4). Heart failure 
may occur due to impaired heart filling 
(diastolic dysfunction) or impaired 
contraction and emptying (systolic 
dysfunction). Although there are many 
studies on diastolic and systolic disorders 
in young adults with diabetes mellitus (8-
10), evidence on children and adolescents 
with DM is scarce (11). In recent years, as 
a roughly independent preload method, 
Tissue Doppler Imaging (TDI) has been 
developed as a novel and sensitive 
technique for assessing diastolic function 
based on wall motility velocity 
measurement. Using TDI, general and 
regional diastolic ventricular dysfunction 
can be diagnosed in a variety of heart 
diseases (12). Considering that 
cardiovascular complications are among 
the predominant complications of diabetes, 
it is crucial to diagnose and control its 
complications especially when the disease 
is developed at younger ages. 
Additionally, due to the high mortality and 
morbidity as well as the high cost of 
treatment, it is essential to determine and 
monitor the myocardial diseases in 
diabetic patients prior to the development 
of signs and symptoms of heart failure. 
The aim of this study was to evaluate the 
cardiac dysfunction in children and 
adolescents suffering from Type 1 
Diabetes Mellitus (T1DM).  
2- MATERIALS AND METHODS 
2-1. Study design and population 
       In this case-control study, a total of 50 
children and adolescents aged 3-19 years 
old with T1DM (cases group) for at least 
two years, referred to the endocrine clinic 
of Shahrekord University of Medical 
Sciences (SKUMS), Iran, were enrolled.  
2-2. Methods 
The control group consisted of 50 healthy 
children and adolescents frequently 
matched by sex and age with the case 
group, and neither suffering from chronic 
disease nor having history of taking drugs 
producing or affecting cardiovascular 
complications. Using a study that reported 
Tei index in the same patient groups (x1= 
0.43± 0.08), (x2= 0.47± 0.07), alpha = 
0.05 with 0.75 power, minimum sample 
size required 50 in each group (13). 
Sample size was calculated using Stata 
software by the formula used for 
calculating means samples. Cases were 
selected through a census over a six-month 
Rostampour et al. 
Int J Pediatr, Vol.8, N.8, Serial No.80, Aug. 2020                                                                                           11729 
period in endocrine clinic of SKUMS.  
Simultaneously with the selection of cases, 
controls were randomly selected using 
simple random sampling by random 
number table in children and adolescents 
admission list from the clinics of SKUMS.  
2-3. Anthropometric measurements 
First, data including age, sex, time of onset 
of diabetes, daily intake of insulin, and 
history of drug consumption were 
collected. After the patient's demographic 
data was collected and physical 
examination was performed, the height, 
weight and BMI of the patients were 
measured. After medical history recording 
and physical examination, the height and 
weight of the patients were measured by a 
pediatric endocrinologist with a scale 
(Seca, Germany), weight and height to the 
nearest 0.1 cm for height and 0.1 kg for 
weight. Patients' height was measured 
using a standard wall height gauge, with 
the legs, knees, hips, shoulders and back 
along the spine perpendicular and straight 
lines and arms freely on either side. 
Patients' blood pressure was measured 
using a barometer with a cuff fitted to the 
patient's arm after 15 minutes of 
relaxation. The control group consisted of 
50 healthy children and adolescents 
referred to the clinic for examination 
matched by sex and age with the patients 
group and neither suffering from chronic 
disease nor having history of taking drugs 
producing or affecting cardiovascular 
complications. The results of three HbA1C 
tests over one year were collected from 
patients’ medical records to determine the 
degree of diabetes management. The mean 
HbA1C was calculated and recorded in the 
questionnaire including demographic data, 
echocardiography data, and tests for all 
participants. 
2-4. Laboratory measurements 
Then, 4-ml blood samples of brachial vein 
were taken to measure Fasting Blood 
Sugar (FBS), High triglyceride (TG), 
cholesterol, high-density 
lipoprotein cholesterol (HDL), and low-
density lipoprotein LDL levels. Samples 
were taken at 8:00 am after overnight 
fasting and before the injection of insulin. 
Random microalbumin and creatinine of 
urine were also investigated. FBS was 
measured by enzymatic, calorimetric and 
single-point measurements by photometric 
method at a wavelength of 546 nm using 
Pars Azmoon kit (Iran). In this procedure, 
the hydrogen peroxide released from 
glucose formed Kinonimin after reacting 
with phenol and 4-amino-antipyrin in the 
presence of the peroxidase enzyme. The 
amount of produced kinonimin has a direct 
correlation with glucose level. To measure 
TG with Pars Azmoon, Iran kit, glycerol 
was first isolated from fatty acids using 
lipoprotein lipase, and then the released 
hydrogen peroxide from glycerol reacted 
with 4-amino-antipyrin and phenol in the 
presence of the peroxidase enzyme and 
formed kinonimin. The amount of 
produced kinonimin has a direct 
correlation with TG.  
To measure cholesterol using a Pars 
Azmoon kit (Iran), hydrogen peroxide 
produced as a result of hydrolysis and 
oxidation of cholesterol, reacted with 
phenol and 4-amino-antipyrin in the 
vicinity of the peroxidase enzyme, formed 
kinonimin. The amount of kinonimin was 
measured photometrically at 546 nm, 
which has positive correlation with the 
amount of cholesterol. HDL and LDL 
levels were determined by photometric 
methods without the need for any 
centrifugation. In this method, antibodies 
eliminate the human lipoproteins except 
the targeted lipoprotein and only the 
concentration of the specific lipoprotein is 
calculated using an enzymatic dye 
reaction. FBS, TG, cholesterol, HDL, and 
LDL tests were measured using a 
calorimetric method. The obtained data 
were documented in the questionnaire. 
Patients were divided into 3 groups based 
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on their mean HbA1C during the last year: 
6-7.5, 7.6-9.9, and over 10 (13). 
2-5. Doppler and Tissue Doppler 
imaging measurements 
Doppler echocardiography was performed 
using Philips 2-4 MHZ transducer. All 
patients were investigated in left lateral 
position. Several Doppler and 2D planes 
were used. Ventricular dimensions were 
measured based on the American Society 
of Echocardiography guideline. Maximal 
initial filling speed (E), and delay (A) were 
obtained through the flow velocity of the 
atrio-ventricular valve. Then, the ratio of 
maximum velocity of the early to late the 
mitral valve (E/A) was measured.  
Based on the TDI and pulse-view (PW) 
activation, the tissue Doppler function was 
recorded on the same device, and the heart 
muscle wall velocity was recorded at the 
base of the septum. During the systole, 
when the impulse moves toward the apex 
of the heart, a steady positive motion (S 
wave) is recorded. During diastole, when 
the impulse moves to the heart base, two 
severe negative movements are recorded, 
one in the initial phase of the diastole (E 
'or Em wave) and the other one in the late 
phase of the diastole (A' or Am wave);  
their maximum speed was recorded.  
Also, the E/E' ratio, which indicates the 
ratio of the primary flow of the valve to 
the wall diastolic wave, and the ratio of 
E'/A' were calculated. These ratios are in 
fact the criteria for measuring diastolic 
cardiac function. It should be noted that 
IVCT was calculated from the end of the 
diastolic wave (A') to the onset of the 
wave S, and IVRT from the end of the 
wave S to the onset of the primary 
diastolic wave E' as well as ET from the 
initiation to the end of the wave S. MPI is 
an echocardiographic time interval that 
includes both systolic and diastolic 
distances, and creates a combined index of 
total ventricular function. MPI was 
calculated using the (IVCT + IVRT)/ET 
formula. In addition to the above 
information, SV, EDV, ESV and EF were 
also measured by echocardiography. 
Noticeably, in this study EF and IVCT 
were considered as criteria for cardiac 
systolic function and IVRT, E/A, E/E' and 
E'/A' ratios were considered as the 
standard diastolic function of the heart. 
Also, MPI is considered as a general 
measure of myocardial function in both 
systolic and diastolic systems.  
2-6. Ethical consideration 
Written consent to participate in the study 
was obtained from all participants and 
their parents (ID code: 
IR.SKUMS.REC.1396.219). 
2-7. Inclusion and exclusion criteria 
The inclusion criteria were patients with 
T1DM receiving insulin therapy, duration 
of T1DM being over 2 years, not suffering 
from other severe illnesses affecting the 
cardiac function, not using cardiac 
function modifying drugs, not having 
definitively diagnosed heart disease, not 
having hypertension and microvascular 
complications of diabetes. 
2-8. Data Analyses  
All continuous values are expressed as 
mean ± standard deviation (SD), and 
categorical variables are presented as 
percentage. Kolmogorov-Smirnov test was 
used to evaluate data distribution. The t-
test was employed to compare differences 
in means of continuous variables between 
two groups. Chi-square and Pearson 
correlation coefficient were used to 
compare the relationship between 
qualitative and quantitative variables 
respectively. Data were analyzed by Stata 
software (Stata Corp. 2018. Stata 
Statistical Software: Release 15.1 College 
Station, TX: Stata Corp LP). P- value of 
less than 0.05 was considered as 
significant. 
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3- RESULTS 
      The study population included 50 
children having T1DM and 50 healthy 
children. Of the patients, 42% (n=21) were 
males and 58% (n=29) were females and 
in control group 48% (n=24) were males 
and 52% (n=26) were females. The control 
group was matched for sex and age with 
studied group and were healthy. The mean 
duration of diabetes mellitus in the case 
group was 4.88±2.16 years. The mean 
ratio of urinary microalbumin to creatinine 
was 14.69 ± 6.16, which was in the normal 
level in all 50 patients and none had 
microalbuminuria. According to Table.1, 
there was no significant difference in age, 
BMI and diastolic blood pressure between 
the two studied groups, but the systolic 
blood pressure was significantly higher in 
the diabetic group compared to the control 
group (p<0.05). To compare the 
echocardiographic findings of two studied 
groups, the independent t-test was used 
and the obtained results are listed in 
Table.2. The mean MPI, E/A, E'/A', E 
wave, A wave, IVRT, ET, EDV, LVIDd 
and LVIDs showed significant difference 
between diabetic and control groups (p< 
0.05), but the mean EF, E/E', IVCT, ESV 
and HF showed no significant difference 
between the diabetic and control groups 
(p> 0.05). 
    
 Table-1: Comparison of demographic indicators in two groups of diabetes and control. 
Variables Mean± Standard Deviation P- value 
Age (year) Diabetic 12.1±3.8 0.3156 
 Control 11.4±2.8  
BMI (kg/m2) Diabetic 18.6±2.9 0.5642 
 Control 18.3±2.1  
SBP (mmHg) Diabetic 106.9±8 0.0307 
 Control 102.9±10  
DBP (mmHg) Diabetic 68±6.7 0.5277 
 Control 67±8.8  
BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure. 
 
Table-2: Comparison of measured variables in TDI echocardiography in two groups of diabetes and 
control.  
Variables Mean± Standard Deviation P- value 
 Diabetic Control  
E wave 87.5±14.1 95.6±17.08 0.012 
A wave 56.9±11.5 51.06±11.3 0.012 
A wave 6.9±1.5 6.2±1.6 0.30 
E/E 7.5±1.6 7.4±1.4 0.8094 
E/A 1.7±0.5 2.1±0.5 0.001 
E/A 1.5±0.4 1.9±0.4 0.001 
IVRT 55.4±13.1 49.2±8.6 0.006 
IVCT 53.7±9.09 51.5±6.6 0.175 
ET 260.04±19.6 273.6±23.2 0.002 
MPI 0.41±0.06 0.36±0.03 0.001 
HR 92.02±12.4 88.1±10.9 0.098 
EF 65.4±6.7 64.4±4.4 0.2473 
ESV 24.06±17.4 26.8±8.2 0.301 
EDV 63.6±19.3 74.8±19.9 0.005 
LVIDd 3.7±0.5 4.08±0.4 0.001 
LVIDs 2.4±0.4 2.7±0.7 0.012 
E: early diastolic wave; A: late (atrial) diastolic wave; A’: late diastolic wave( by tissue Doppler); E’:early 
diastolic wave(by tissue Doppler); IVRT: isovolemic relaxation time; IVCT: isovolemic contraction time; ET: 
ejection  tim; MPI: myocardial performance index; HR: heart rate; EF: ejection fraction; ESV: end systolion 
volume; EDV: end diastolic volume; LVIDd: left ventricular diastolic iternal diamention; LVIDs: left 
ventricular systolic iternal diameter. 
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To investigate the relationship between 
echocardiography factors with Chol, TG, 
HDL, LDL, HbA1C and duration of 
disease in diabetic patients, Pearson 
correlation test was used (Table.3). Based 
on the results, the significant positive 
correlation was observed between E/E' 
with serum TG level (p = 0.0072, r=0.37). 
E'/A' ratio showed significantly negative 
correlation with TG level (p = 0.014, r=-
0.347), and significantly positive 
correlation with HDL (p = 0.033). E/A 
ratio had a significant correlation with TG 
levels (p = 0.048, r=-0.281), LDL (p = 
0.012, r=-0.352), and HDL (p = 0.046, 
r=0.284), though this relationship was 
inverse for the LDL and TG with E/A 
ratio. The analysis of the 
echocardiographic indices of MPI, EF, 
E/E′ with three subclasses of HbA1C is 
shown in Table.4. The results of this 
categorization outlined that despite all the 
differences between indices of MPI (P = 
0.063), EF (p = 0.453) and E/E′ ratio (p = 
0.229) in the three groups of HbA1C, none 
of these differences were statistically 
significant (p>0.05). 
 
 
Table-3: Pearson correlation coefficient regarding measured parameters in echocardiography with 
serum lipids and duration of diabetes.  
Variables HbA1C 
(%) 
Cholesterol 
(mg/dl) 
TG 
(mg/dl) 
LDL 
(mg/dl) 
HDL 
(mg/dl) 
duration of 
diabetes 
(year) 
MPI R = -0.2651 
R = 0.0628 
R = -0.25 
R = 0.07 
R = 0.04 
R = 0.749 
R = -0.27 
R = 0.0523 
R = 0.18 
R = 0.2078 
R = -0.0224 
R = 0.877 
EF R = 0.14 
R = 0.3198 
R = -0.22 
R = 0.112 
R = 0.023 
R = 0.8695 
R = -0.13 
R = 0.3646 
R = -0.18 
R = 0.2015 
R = -0.17 
R = 0.237 
E/E R = 0.0406 
R = 0.796 
R = 0.14 
R = 0.323 
R = 0.37 
R = 0.0072* 
R = 0.08 
R = 0.558 
R = -0.11 
R = 0.43 
R = -0.07 
R = 0.586 
E/A R = -0.28 
R = 0.845 
R = -0.009 
R = 0.948 
R = -0.347 
R = 0.014 
R = -0.18 
R = 0.901 
R = 0.302 
R = 0.033 
R = 0.915 
R = 0.095 
E/A R = 0.011 
R = 0.937 
R = -0.206 
R = 0.152 
R = -0.281 
R = 0.048 
R = -0.352 
R = 0.012 
R = 0.284 
R = 0.046 
R = 0.246 
R = 0.085 
TG: triglyceride; LDL: low density lipoprotein; HDL: high density lipoprotein. 
 
 Table-4: Relationship between measured parameters in echocardiography with HbA1C. 
Variables Good (6-7.5) Intermediate  (7.6-9.9) Poor ≥ 10 Total 
E/E Normal 4 8 2 14 
 Non-normal 4 21 11 36 
MPI Normal 0 13 5 18 
 Non-normal 8 16 8 32 
EF Normal 6 26 12 44 
 Non-normal 2 3 1 6 
MPI: myocardial Performance Index; E: early diastolic wave; E’: early diastolic wave (by tissue Doppler); EF: 
Ejection Fraction. 
4- DISCUSSION 
      The present study was conducted on 50 
diabetic children and 50 healthy children 
matched for age, BMI and DBP. In this 
study, the parameters obtained by TDI 
echocardiography were compared in two 
control and case groups and based on the 
independent t-test, the mean MPI, E/A, 
E'/A', E wave, A wave, IVRT, ET, EDV, 
LVIDs, and LVIDs were significantly 
different between two groups of diabetic 
and control (p<0.05), but EF, E/E', IVCT, 
ESV and HF showed no significant 
difference (p>0.05). It should be noted that 
in this study, EF and IVCT were 
considered as criteria for cardiac systolic 
function and IVRT, E/A, E/E' and E'/A' as 
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criteria for cardiac diastolic function. The 
major finding in our study was that the left 
ventricular diastolic dysfunction can be 
detected even in the presence of normal 
systolic function of this ventricle in people 
with T1DM by TDI. Most of previous 
studies have investigated impairment of 
cardiac myocardial function in adults, 
while studies on children are limited. In 
2014, in a study conducted in Egypt by 
Khattab  and Soliman on 30 children with 
T1DM and 20 healthy controls, the mean 
MPI, E/A, E'/A', IVRT, A wave and E 
waves were significantly different between 
the case and control groups (14).  
These results were inconsistent with the 
results of the present study. In another 
study performed on 48 children with 
T1DM, and 30 healthy controls, EF was 
not significantly different between the 
patients and the control groups, but the 
waves E and A showed significant 
difference between patient and control 
groups, which are in agreement with our 
results (15). It is stated in the previous 
studies that diastolic dysfunction has been 
observed in people with DM, even in the 
presence of normal EF. In fact, it can be 
argued that diastolic dysfunction is one of 
the first signs of diabetic cardiomyopathy 
and the presence of diastolic dysfunction 
in the affected subjects with DM alone is a 
risk factor for heart failure, which affects 
patient prognosis (15). In a study 
conducted in Turkey in 2016 on 84 
children and adolescents with diabetes 
mellitus and 32 healthy individuals, the 
mean E/E' and EF ratio had no significant 
difference between two groups; but the 
mean E/A ratio was 1.6 in the case group 
and 1.79 in the control group, which was 
statistically significant (16). This result 
was in line with the result of our study. 
Furthermore, the above cited study 
suggested that impaired cardiac diastolic 
function in children and adolescents with 
T1DM was diagnosed by Doppler 
echocardiography in the previous studies, 
but the E/E′ ratio showed no significant 
difference between patient and control 
group. Also, several studies have reported 
that the relationship between the 
determinants of cardiac dysfunction in TDI 
is controversial and contrasts with the 
increase in blood glucose levels in children 
with T1DM )16(. A study by Salem et al. 
in Egypt on 40 children with T1DM and 
20 healthy children, the mean of MPI and 
E/A and E'/A' were significantly different 
between the two groups )17(. These 
findings were similar to those obtained in 
our study. It is also noted that early stages 
of myocardial dysfunction in people with 
diabetes, even in case of the normal heart 
function, can be identified and diagnosed 
by the echocardiography )17(. A study 
conducted in Greece by Vazeou et al., on 
42 children with T1DM and 43 control 
children showed that in absence of 
microangiopathy in the patient group, there 
was no significant difference between 
cardiac systolic and diastolic function 
between the patient and control groups. 
However, this difference was significant 
when patients with microangiopathy were 
selected. In this study, the mean age of 
patients was 18.4 and the mean duration of 
diabetes mellitus was 9.9 years (18).  
However, in our study, the mean age of 
patients was 12.1 years and the mean 
duration of the disease was 4.88 years. 
This could explain the difference in the 
results of Vazeou et al.’s study and our 
study results (18). Considering that in our 
study none of the patients had micro and 
macrovascular diabetes complications and 
also considering the results of Vazeou et 
al.’s study (18), it can be said that the lack 
of significant difference in the EF and E/E′ 
indices between the two groups of patients 
and the control group is due to the absence 
of microangiopathy. In a study conducted 
by Zorofyan et al., in Tehran in 2014 on 37 
adult type II diabetic patients with normal 
blood pressure and coronary artery and EF 
above 50% compared to 39 healthy 
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controls, the mean MPI and E/A showed a 
significant difference between these two 
groups, which was consistent with our 
study. Also, the mean E/E′ was 6.6 in 
patients and 6.01 in control group (p<0.05) 
(18). This finding was not in line with the 
results of our study, which can be because 
the population of patients in the above 
study was adult with type II diabetes (19). 
In a collaborative study conducted 
between Japan and the United States on 60 
adult diabetic patients and 25 healthy 
volunteers, the mean E/A ratio was 
significantly different between the two 
groups, but the mean EF showed no 
significant difference. This study 
suggested that EF is not an appropriate and 
sensitive indicator for the diagnosis of 
systolic subclinical disorders in diabetic 
patients (20), which is in line with our 
study. In Nakai et al. (20), the mean E/E′ 
was 12.9 in patients and 9.1 in healthy 
subjects, which had significant difference 
(20), and was incongruous with our study.  
In other words, in the adult population E/E′ 
ratio in diabetic patients was significantly 
higher than in healthy adults, but in our 
study, there was no significant difference 
between the two healthy and patients’ 
populations, which can be due to the lower 
age and shorter duration of diabetes as 
well as the absence of diabetic 
complications in the patients in our study.  
In the present study, based on the Pearson 
correlation analysis in patients with 
T1DM, significant relationship was 
observed positively between E/E' ratio and 
TG and also between E/A with HDL, but 
negatively between TG and LDL. Also, 
E/A' showed significantly positive 
correlation with HDL, but significantly 
negative relationship with TG. In a study 
by Adal et al. in Turkey on diabetes 
mellitus in children and adolescents, it was 
reported that in those with an average 
diabetes mellitus duration of 8 years, there 
was a significant relationship between 
LDL, HDL, HbA1c and cardiac function, 
but these relationships were not significant 
in those with diabetes mellitus duration of 
3.5 years (21). This can justify the results 
of our study as the mean duration of 
diabetes was 4.8 years in our study. 
Studies have reported that the pathogenesis 
of diabetic cardiomyopathy is 
multifactorial that can include 
microvascular involvement, changes in 
myocardial metabolism, and structural 
changes in myocardial infarction due to 
fibrosis. Evidence indicated that deposition 
of lipids in the myocardium leads to 
myocardial damage in the heart.  
Insulin resistance increases the intake and 
withdrawal of fatty acids in the 
myocardium and the accumulation of TG 
in the myocardium. It seems that this 
accumulation is associated with 
mitochondrial dysfunction, which causes 
cellular damage, apoptosis, and ultimately 
replacement of fibrosis (22). The above 
mentioned evidence can justify the 
presence of significant relationship 
between E/A, E'/A' and E/E' with the 
serum TG level in our study. Studies have 
also suggested that the increasing risk of 
heart disease in people with diabetes may 
be related to controlling blood glucose 
levels. However, no significant 
relationship was reported between diastolic 
dysfunction and HbA1c in previous studies 
(14, 17, 23). 
5- CONCLUSION 
      Based on the results, in diabetic 
patients, first cardiac diastolic function 
decreases, which results in a decrease in 
E/A and E/A ratios, as well as a decrease 
in myocardial performance index, which 
indicates systolic and diastolic function, 
and is recommended to be taken into 
account in the initial examination of the 
heart of diabetics and not to wait for late-
onset systolic function change, and the E / 
E1 ratio is directly related to serum TG 
elevation.  
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